Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
Importantly, our study highlights an unusual target on DCs—the α chain of complement receptor 4 (CR4) (CD11c)—for therapeutic interventions in HIV-1 treatment. Targeting CD11c on DCs mediated a potent antiviral immune response via clustering of CR4 and CCR5 and subsequent opening of an antiviral re...
Guardado en:
Autores principales: | Wilfried Posch, Marta Bermejo-Jambrina, Marion Steger, Christina Witting, Gabriel Diem, Paul Hörtnagl, Hubert Hackl, Cornelia Lass-Flörl, Lukas A. Huber, Teunis B. H. Geijtenbeek, Doris Wilflingseder |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6bf2a44de32345d8b59615a811b9661a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.
por: Zoltán Bánki, et al.
Publicado: (2010) -
ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia
por: W. Posch, et al.
Publicado: (2021) -
Alteration of complement hemolytic activity in different trauma and sepsis models
por: Ehrnthaller C, et al.
Publicado: (2012) -
Art as Complement of Philosophy
por: Elisabetta Sacchi, et al.
Publicado: (2018) -
Type I interferon sensing unlocks dormant adipocyte inflammatory potential
por: Calvin C. Chan, et al.
Publicado: (2020)